146.00
price down icon1.72%   -2.56
pre-market  시장 영업 전:  145.85   -0.15   -0.10%
loading
전일 마감가:
$148.56
열려 있는:
$147.11
하루 거래량:
5.55M
Relative Volume:
0.77
시가총액:
$181.25B
수익:
$29.45B
순이익/손실:
$8.51B
주가수익비율:
21.53
EPS:
6.7823
순현금흐름:
$9.46B
1주 성능:
-1.50%
1개월 성능:
-6.29%
6개월 성능:
+23.88%
1년 성능:
+27.59%
1일 변동 폭
Value
$145.81
$149.30
1주일 범위
Value
$142.77
$149.38
52주 변동 폭
Value
$93.37
$157.29

길리어드 사이언스 Stock (GILD) Company Profile

Name
명칭
Gilead Sciences Inc
Name
전화
(650) 574-3000
Name
주소
333 LAKESIDE DR, FOSTER CITY, CA
Name
직원
17,000
Name
트위터
@GileadSciences
Name
다음 수익 날짜
2026-04-23
Name
최신 SEC 제출 서류
Name
GILD's Discussions on Twitter

Compare GILD vs LLY, JNJ, ABBV, AZN, NVS

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - General icon
GILD
Gilead Sciences Inc
146.00 181.25B 29.45B 8.51B 9.46B 6.7823
Drug Manufacturers - General icon
LLY
Lilly Eli Co
999.84 892.85B 65.18B 20.64B 5.96B 22.59
Drug Manufacturers - General icon
JNJ
Johnson Johnson
242.99 585.58B 94.19B 26.80B 19.70B 11.05
Drug Manufacturers - General icon
ABBV
Abbvie Inc
227.68 402.58B 61.16B 4.19B 17.82B 2.3614
Drug Manufacturers - General icon
AZN
Astrazeneca Plc
193.31 299.79B 58.80B 10.24B 8.98B 3.2788
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
155.80 297.29B 54.72B 14.02B 15.32B 7.1855

길리어드 사이언스 Stock (GILD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2026-03-10 개시 Jefferies Buy
2026-02-20 개시 Barclays Equal Weight
2026-02-11 재확인 Needham Buy
2026-01-07 재개 UBS Buy
2025-11-24 재개 Truist Buy
2025-11-13 개시 Scotiabank Sector Outperform
2025-08-19 업그레이드 Daiwa Securities Neutral → Outperform
2025-08-08 업그레이드 Truist Hold → Buy
2025-07-25 업그레이드 Needham Hold → Buy
2025-04-22 재개 Cantor Fitzgerald Overweight
2025-03-04 재확인 Oppenheimer Outperform
2025-02-18 업그레이드 Deutsche Bank Hold → Buy
2025-02-13 업그레이드 DZ Bank Hold → Buy
2025-01-10 업그레이드 Morgan Stanley Equal-Weight → Overweight
2024-12-10 재개 BofA Securities Buy
2024-11-15 개시 Wolfe Research Outperform
2024-11-14 개시 Citigroup Buy
2024-11-08 다운그레이드 Maxim Group Buy → Hold
2024-10-21 업그레이드 Leerink Partners Market Perform → Outperform
2024-10-17 개시 Bernstein Outperform
2024-10-07 업그레이드 Wells Fargo Equal Weight → Overweight
2024-07-08 업그레이드 Raymond James Mkt Perform → Outperform
2024-05-01 재확인 Maxim Group Buy
2024-04-24 업그레이드 HSBC Securities Reduce → Hold
2024-02-22 다운그레이드 Truist Buy → Hold
2023-11-09 개시 Deutsche Bank Hold
2023-09-08 업그레이드 BofA Securities Neutral → Buy
2023-09-06 개시 HSBC Securities Reduce
2023-07-24 재확인 Barclays Equal Weight
2023-05-16 업그레이드 BMO Capital Markets Market Perform → Outperform
2023-04-28 재개 Piper Sandler Overweight
2023-01-03 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2022-12-13 재개 BofA Securities Neutral
2022-12-09 다운그레이드 DZ Bank Buy → Hold
2022-10-31 업그레이드 Barclays Underweight → Equal Weight
2022-10-28 재확인 BMO Capital Markets Market Perform
2022-10-28 재확인 Cowen Outperform
2022-10-28 재확인 JP Morgan Overweight
2022-10-28 재확인 Jefferies Buy
2022-10-28 업그레이드 Piper Sandler Neutral → Overweight
2022-10-28 재확인 RBC Capital Mkts Outperform
2022-10-28 업그레이드 Truist Hold → Buy
2022-10-28 재확인 Wells Fargo Equal Weight
2022-10-04 업그레이드 JP Morgan Neutral → Overweight
2022-07-13 개시 Cantor Fitzgerald Neutral
2022-05-23 개시 SVB Leerink Mkt Perform
2022-02-28 다운그레이드 BMO Capital Markets Outperform → Market Perform
2022-02-02 재확인 BMO Capital Markets Outperform
2022-02-02 재확인 BofA Securities Neutral
2022-02-02 재확인 RBC Capital Mkts Outperform
2022-02-02 재확인 Truist Hold
2022-02-02 재확인 Wells Fargo Equal Weight
2022-01-28 업그레이드 Argus Hold → Buy
2022-01-06 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2021-12-09 재개 Wells Fargo Equal Weight
2021-12-06 개시 Goldman Neutral
2021-11-19 업그레이드 BMO Capital Markets Market Perform → Outperform
2021-11-19 재개 Piper Sandler Neutral
2021-10-20 재개 Cowen Outperform
2021-07-30 재확인 BMO Capital Markets Market Perform
2021-07-30 재확인 RBC Capital Mkts Outperform
2021-04-01 업그레이드 Bernstein Mkt Perform → Outperform
2021-03-30 업그레이드 Redburn Neutral → Buy
2021-01-19 업그레이드 Morgan Stanley Equal-Weight → Overweight
2021-01-04 업그레이드 Guggenheim Neutral → Buy
2020-11-03 재개 Morgan Stanley Equal-Weight
2020-10-28 개시 UBS Neutral
2020-09-30 재개 Jefferies Buy
2020-09-15 업그레이드 Maxim Group Hold → Buy
2020-07-31 재확인 Credit Suisse Neutral
2020-07-31 재확인 Morgan Stanley Equal-Weight
2020-07-31 재확인 Piper Sandler Overweight
2020-07-31 재확인 RBC Capital Mkts Outperform
2020-07-31 재확인 SunTrust Hold
2020-07-31 재확인 Wells Fargo Equal Weight
2020-07-20 업그레이드 Credit Suisse Underperform → Neutral
2020-06-03 업그레이드 SVB Leerink Mkt Perform → Outperform
2020-05-26 업그레이드 SunTrust Sell → Hold
2020-05-01 다운그레이드 JP Morgan Overweight → Neutral
2020-05-01 다운그레이드 Raymond James Outperform → Mkt Perform
2020-05-01 다운그레이드 SunTrust Hold → Sell
2020-04-27 다운그레이드 UBS Buy → Neutral
2020-04-20 다운그레이드 BMO Capital Markets Outperform → Market Perform
2020-04-20 다운그레이드 Wells Fargo Overweight → Equal Weight
2020-04-17 다운그레이드 CFRA Hold → Sell
모두보기

길리어드 사이언스 주식(GILD)의 최신 뉴스

pulisher
04:39 AM

Bokf Na Raises Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

04:39 AM
pulisher
Mar 11, 2026

HER2-Negative Metastatic Breast Cancer Market Expected to Transform Significantly Through 2034, According to DelveInsight | Genentech, AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene - StreetInsider

Mar 11, 2026
pulisher
Mar 11, 2026

News | British Land and Royal London sign Gilead at Euston development - CoStar

Mar 11, 2026
pulisher
Mar 11, 2026

Gilead’s US$7.8b Arcellx Deal Deepens Cell Therapy Diversification - simplywall.st

Mar 11, 2026
pulisher
Mar 11, 2026

Gilead Sciences, Inc. $GILD Shares Sold by Mackenzie Financial Corp - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

Magnetar Financial LLC Increases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 11, 2026
pulisher
Mar 10, 2026

Gilead at Leerink Conference: Strategic Expansion in Healthcare - Investing.com India

Mar 10, 2026
pulisher
Mar 10, 2026

Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street’s Latest Biopharma Calls Explained - AOL.com

Mar 10, 2026
pulisher
Mar 10, 2026

Jefferies Initiates Coverage on Gilead Sciences (GILD) with 'Buy' Rating | GILD Stock News - GuruFocus

Mar 10, 2026
pulisher
Mar 10, 2026

Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained - 24/7 Wall St.

Mar 10, 2026
pulisher
Mar 10, 2026

What 16 Analyst Ratings Have To Say About Gilead Sciences - Benzinga

Mar 10, 2026
pulisher
Mar 10, 2026

Gilead Sciences (NASDAQ:GILD) Now Covered by Analysts at Jefferies Financial Group - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Gilead price boosted by important supportForecast today10-03-2026 - Economies.com

Mar 10, 2026
pulisher
Mar 10, 2026

Gilead Sciences, Inc. $GILD Shares Sold by Richard Bernstein Advisors LLC - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Gilead Sciences, Inc. $GILD Stock Position Decreased by Capital Research Global Investors - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Gilead Sciences, Inc. $GILD Holdings Trimmed by Capital World Investors - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Capital International Inc. CA Raises Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Jefferies initiates Gilead Sciences stock with buy rating By Investing.com - Investing.com Canada

Mar 10, 2026
pulisher
Mar 10, 2026

Legal & General Group Plc Buys 414,454 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Russell Investments Group Ltd. Sells 49,215 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Fieldview Capital Management LLC Invests $1.91 Million in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

GILEAD SCIENCES INC (NASDAQ:GILD): A Durable Dividend Stock for Income Investors - ChartMill

Mar 10, 2026
pulisher
Mar 10, 2026

Jefferies initiates Gilead Sciences stock with buy rating - Investing.com

Mar 10, 2026
pulisher
Mar 10, 2026

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Gilead to Acquire Arcellx, Inc. (ACLX) for Up to $7.8 billion - Insider Monkey

Mar 10, 2026
pulisher
Mar 10, 2026

Banque Cantonale Vaudoise Has $8.91 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 10, 2026
pulisher
Mar 09, 2026

Gilead Sciences (GILD) Outperforms Broader Market: What You Need to Know - Yahoo Finance

Mar 09, 2026
pulisher
Mar 09, 2026

How Low Can Gilead Sciences Stock Really Go? - Trefis

Mar 09, 2026
pulisher
Mar 09, 2026

Swiss National Bank Has $398 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

Schroder Investment Management Group Has $230.08 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

Gilead Sciences, Inc. $GILD Shares Purchased by WINTON GROUP Ltd - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

Vinva Investment Management Ltd Increases Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

Gilead Sciences, Inc. $GILD Shares Bought by Kiltearn Partners LLP - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

Natixis Advisors LLC Raises Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

B. Metzler seel. Sohn & Co. AG Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

Citigroup Maintains Buy on GILD (Gilead Sciences, Inc.) March 2026 - Meyka

Mar 09, 2026
pulisher
Mar 08, 2026

Arcellx set to report earnings amid $7.8B Gilead deal - Investing.com

Mar 08, 2026
pulisher
Mar 08, 2026

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Has $2.81 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 08, 2026
pulisher
Mar 08, 2026

Parallel Advisors LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 08, 2026
pulisher
Mar 08, 2026

Korea Investment CORP Boosts Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 08, 2026
pulisher
Mar 08, 2026

Rhenman & Partners Asset Management AB Sells 88,000 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Mar 08, 2026
pulisher
Mar 08, 2026

Gilead Sciences, Inc. $GILD Shares Sold by Blair William & Co. IL - MarketBeat

Mar 08, 2026
pulisher
Mar 07, 2026

Is It Time To Reassess Gilead Sciences (GILD) After Its Strong Share Price Run - Yahoo Finance

Mar 07, 2026
pulisher
Mar 07, 2026

Gilead’s BIC LEN HIV Results Highlight Valuation Gap And Future Potential - Yahoo Finance

Mar 07, 2026
pulisher
Mar 07, 2026

Gilead Sciences, Inc. $GILD Shares Purchased by HUB Investment Partners LLC - MarketBeat

Mar 07, 2026
pulisher
Mar 07, 2026

Munich Reinsurance Co Stock Corp in Munich Takes $67.50 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 07, 2026
pulisher
Mar 07, 2026

First Trust Advisors LP Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 07, 2026
pulisher
Mar 07, 2026

GILD Stock Quote Price and Forecast - CNN

Mar 07, 2026
pulisher
Mar 06, 2026

Is Gilead Sciences Inc. stock overvalued by current metricsWeekly Trade Review & Low Drawdown Momentum Trade Ideas - Naître et grandir

Mar 06, 2026
pulisher
Mar 06, 2026

These 3 Cash Flow Machines Provide Stability in Uncertain Markets - Investing.com

Mar 06, 2026
pulisher
Mar 06, 2026

Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term - Yahoo Finance

Mar 06, 2026

길리어드 사이언스 (GILD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_general NVO
$38.83
price up icon 0.28%
$377.64
price up icon 0.59%
drug_manufacturers_general PFE
$27.30
price up icon 0.52%
drug_manufacturers_general MRK
$116.21
price down icon 0.75%
drug_manufacturers_general NVS
$155.80
price down icon 3.58%
자본화:     |  볼륨(24시간):